title: Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism.
abstract: The present study was performed to test the hypotheses that allelic variants at the human dopamine D2 receptor gene locus (DRD2) confer susceptibility to alcoholism or are associated with clinical subtypes of alcoholism. We investigated an A --> G substitution polymorphism in the 3'-untranslated region of exon 8 (E8) of DRD2 with allele frequencies of f(G) = 0.295 - 0.329. No significant association of the DRD2 genotype or allele frequencies with alcoholism was found in an association study including 283 alcoholics and 146 non-alcoholic controls. However, the frequent homozygous E8 A/A genotype with f(AA) = 0.47 - 0.48 was associated with increased anxiety and depression scores in alcoholics during the follow up after clinical detoxification treatment. In addition, E8 A/A was associated with increased suicide attempts and showed a tendency towards more severe withdrawal symptoms, early relapse and reduced responsiveness to the dopaminergic agonist apomorphine. Regression analysis revealed the DRD2 E8 genotype as the only significant factor determining withdrawal severity in female alcoholics. The findings suggest an influence of the DRD2 genotype on the neuropharmacological effects of chronic alcohol exposure and the clinical course of alcoholism.
authors.affiliation: Working group for Molecular Neurobiology, Institute of Neuropsychopharmacology, Free University Berlin, Germany. finckh@plexus.uke.uni-hamburg.de
authors.forename: U
authors.initials: U
authors.lastname: Finckh
authors.forename: H
authors.initials: H
authors.lastname: Rommelspacher
authors.forename: S
authors.initials: S
authors.lastname: Kuhn
authors.forename: P
authors.initials: P
authors.lastname: Dufeu
authors.forename: G
authors.initials: G
authors.lastname: Otto
authors.forename: A
authors.initials: A
authors.lastname: Heinz
authors.forename: M
authors.initials: M
authors.lastname: Dettling
authors.forename: M
authors.initials: M
authors.lastname: Giraldo-Velasquez
authors.forename: J
authors.initials: J
authors.lastname: Pelz
authors.forename: K J
authors.initials: KJ
authors.lastname: Gräf
authors.forename: H
authors.initials: H
authors.lastname: Harms
authors.forename: T
authors.initials: T
authors.lastname: Sander
authors.forename: L G
authors.initials: LG
authors.lastname: Schmidt
authors.forename: A
authors.initials: A
authors.lastname: Rolfs
mesh_terms: D000222:Adaptation, Physiological; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000235:genetics* / Q000503:physiopathology* / Q000523:psychology; D001058:Apomorphine / Q000494:pharmacology; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D019382:Human Growth Hormone / Q000097:blood / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D017448:Receptors, Dopamine D2 / Q000235:genetics* / Q000502:physiology*; D013375:Substance Withdrawal Syndrome / Q000235:genetics / Q000503:physiopathology; D013406:Suicide, Attempted
chemical_list: D017448:Receptors, Dopamine D2; D019382:Human Growth Hormone; D001058:Apomorphine